Non-muscle Invasive Bladder Cancer
📧 Sign up to get email alerts when something new happens for Non-muscle Invasive Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: To Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of Disitamab Vedotin in Patients With High-risk Non-muscular Invasive Bladder Cancer (NMIBC) That Express HER2 [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating intravesical Disitamab Vedotin (RC48) for high-risk non-muscle invasive bladder cancer expressing H…
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer [Phase 3]
Phase 3 study evaluating adding mitomycin C to Bacillus Calmette-Guérin for high-risk non-muscle-invasive bladder cancer; the trial is curre…
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer [Phase 3]
A Phase 3 study of UGN-102 for low-grade intermediate-risk non-muscle invasive bladder cancer was terminated, with results posted on 2024-06…
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer [Phase 3]
Phase 3 multicenter trial evaluating intravesical Bacillus Calmette-Guérin (BCG) and alternative BCG protocols for intermediate and high-ris…
-
CLINICAL_TRIALS research · 2024-05-23Clinical Trial Update: Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC Patients [Phase 1]
Phase 1 clinical trial update on intravesical instillation of T3011 for non-muscle-invasive bladder cancer. Sponsored by Fudan University, t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE) [Phase 1]
Phase 1 clinical trial update for atezolizumab plus Bacillus Calmette-Guérin (BCG) in high-risk BCG-naïve non-muscle invasive bladder cancer…
-
CLINICAL_TRIALS trial_result · 2024-03-25Clinical Trial Update: HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer [Phase 3]
A Phase 3 clinical trial update for HIVEC in non-muscle-invasive bladder cancer is currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-02-05Clinical Trial Update: Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC) [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of BCG for preventing postoperative recurrence in medium/high-risk non-muscle inva…
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer [Phase 2]
Phase 2 clinical trial evaluating atezolizumab in recurrent BCG-unresponsive non-muscle invasive bladder cancer has completed, with results …
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG) [Phase 1]
Phase 1 study evaluating the combination of durvalumab and Vicineum in patients with high-grade non-muscle-invasive bladder cancer previousl…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer [Phase 2]
Phase 2 clinical trial update evaluating efficacy and safety of Pseudomonas aeruginosa for intermediate and high-risk non-muscle invasive bl…
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Intravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder Cancer [Phase 2]
Phase 2 trial evaluating intravesical gemcitabine and docetaxel for BCG-naïve non-muscle invasive bladder cancer; results have been posted a…
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer [Phase 1]
Phase 1 trial update evaluating pembrolizumab in combination with intravesical BCG solution for recurrent non-muscle-invasive bladder cancer…
-
CLINICAL_TRIALS trial_result · 2022-10-14Clinical Trial Update: Safety and Efficacy of BCG Combined With Tislelizumab for BCG-untreated Patients With High-risk Non-muscle Invasive Bladder Cancer [Phase 4]
A Phase 4 clinical trial update evaluating safety and efficacy of BCG combined with tislelizumab in patients with high-risk non-muscle-invas…
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer [Phase 2]
Phase 2 clinical trial update evaluating an oncolytic adenovirus in combination with a PD-1 inhibitor for non-muscle-invasive bladder cancer…
-
CLINICAL_TRIALS trial_result · 2022-07-13Clinical Trial Update: ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) [Phase 3]
Phase 3 trial of ADSTILADRIN (INSTILADRIN) in high-grade, BCG-unresponsive non-muscle invasive bladder cancer has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2022-02-22Clinical Trial Update: A Phase 3 Study to Evaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk NMIBC Patients [Phase 3]
Phase 3 study evaluating APL-1202 as a single-agent oral treatment versus intravesical epirubicin in naïve intermediate-risk non-muscle inva…
-
CLINICAL_TRIALS trial_result · 2022-02-22Clinical Trial Update: Safety and Efficacy of APL-1202 in Combination With Epirubicin Hydrochloride Versus Epirubicin Hydrochloride Alone in Intermediate and High-risk Chemo-refractory Non-muscle Invasive Bladder Cancer (NMIBC) Patients [Phase 3]
Phase 3 trial evaluating APL-1202 in combination with epirubicin versus epirubicin alone in chemo-refractory non-muscle invasive bladder can…
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants [Phase 1, Phase 2]
This clinical trial update reports safety and pharmacology results for atezolizumab alone and with BCG in high-risk non-muscle-invasive blad…
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer [Phase 1, Phase 2]
Phase 1/2 trial of ABI-009 in non-muscle invasive bladder cancer completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer [Phase 3]
A Phase 3 clinical trial update for VB4-845 Injection in non-muscle invasive bladder cancer is ongoing, with status not disclosed.
-
CLINICAL_TRIALS trial_result · 2021-04-14Clinical Trial Update: Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer [Phase 2, Phase 3]
Phase 2/3 trial of recombinant adenovirus for non-muscle invasive bladder cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: The Aim of This Study is to Compare the Efficacy of Perioperative Hypertonic Saline 3% Versus Normal Saline (0.9%) in Decreasing Recurrence Risk in Non-muscle Invasive Bladder Cancer [Phase 2]
Phase 2 trial update comparing perioperative hypertonic saline 3% to normal saline for reducing recurrence risk in non-muscle invasive bladd…
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: ONCOFID-P-B in the Intravescical Therapy of Patients With Non-muscle Invasive Cancer of the Bladder. [Phase 2]
Phase 2 clinical trial update for ONCOFID-P-B in intravesical therapy for non-muscle invasive bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-19Clinical Trial Update: A First-in-Human Study of alpha1H in Patients With Non-muscle Invasive Bladder Cancer [Phase 1, Phase 2]
First-in-human study of alpha1H in patients with non-muscle invasive bladder cancer undergoing Phase 1/2 evaluation.